These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 12223451

  • 1. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cells.
    Delgado M, Leceta J, Ganea D.
    FASEB J; 2002 Nov; 16(13):1844-6. PubMed ID: 12223451
    [Abstract] [Full Text] [Related]

  • 2. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M, Reduta A, Sharma V, Ganea D.
    J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
    [Abstract] [Full Text] [Related]

  • 3. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.
    Delgado M, Leceta J, Gomariz RP, Ganea D.
    J Immunol; 1999 Oct 01; 163(7):3629-35. PubMed ID: 10490956
    [Abstract] [Full Text] [Related]

  • 4. VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.
    Delgado M, Gonzalez-Rey E, Ganea D.
    FASEB J; 2004 Sep 01; 18(12):1453-5. PubMed ID: 15231725
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.
    Ganea D, Rodriguez R, Delgado M.
    Cell Mol Biol (Noisy-le-grand); 2003 Mar 01; 49(2):127-42. PubMed ID: 12887096
    [Abstract] [Full Text] [Related]

  • 6. VIP and PACAP enhance the in vivo generation of memory TH2 cells by inhibiting peripheral deletion of antigen-specific effectors.
    Delgado M, Ganea D.
    Arch Physiol Biochem; 2001 Oct 01; 109(4):372-6. PubMed ID: 11935376
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C, Delgado M, Gomariz RP, Ganea D.
    J Immunol; 1996 Jun 01; 156(11):4128-36. PubMed ID: 8666779
    [Abstract] [Full Text] [Related]

  • 8. Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP.
    Ganea D, Delgado M.
    Arch Immunol Ther Exp (Warsz); 2001 Jun 01; 49(2):101-10. PubMed ID: 11348014
    [Abstract] [Full Text] [Related]

  • 9. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433
    [Abstract] [Full Text] [Related]

  • 10. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M, Jonakait GM, Ganea D.
    Glia; 2002 Aug 01; 39(2):148-61. PubMed ID: 12112366
    [Abstract] [Full Text] [Related]

  • 11. VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expression.
    Delgado M, Leceta J, Sun W, Gomariz RP, Ganea D.
    Ann N Y Acad Sci; 2000 Aug 01; 921():68-78. PubMed ID: 11193881
    [Abstract] [Full Text] [Related]

  • 12. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression.
    Delgado M, Ganea D.
    J Immunol; 2000 Feb 01; 164(3):1200-10. PubMed ID: 10640731
    [Abstract] [Full Text] [Related]

  • 13. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity.
    Ganea D, Delgado M.
    Crit Rev Oral Biol Med; 2002 Feb 01; 13(3):229-37. PubMed ID: 12090463
    [Abstract] [Full Text] [Related]

  • 14. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis.
    Delgado M, Gonzalez-Rey E, Ganea D.
    Ann N Y Acad Sci; 2006 Jul 01; 1070():233-8. PubMed ID: 16888172
    [Abstract] [Full Text] [Related]

  • 15. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R.
    J Endocrinol; 2006 Oct 01; 191(1):287-99. PubMed ID: 17065411
    [Abstract] [Full Text] [Related]

  • 16. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug 01; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP.
    J Immunol; 1999 Feb 15; 162(4):2358-67. PubMed ID: 9973516
    [Abstract] [Full Text] [Related]

  • 19. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T, Saito ES, Takahashi H, Saito S, Tomonaga S, Boswell T, Furuse M.
    Regul Pept; 2004 Aug 15; 120(1-3):99-105. PubMed ID: 15177926
    [Abstract] [Full Text] [Related]

  • 20. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I.
    Oncol Rep; 2005 Jun 15; 13(6):1217-21. PubMed ID: 15870945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.